Globavir

I’ve co-founded Globavir, an infectious disease company addressing critical antibiotic resistance threats in the developed countries as well as unmet needs in viral infections around the world. Globavir’s lead program (GBV 006) entered the clinic in early 2015 and a second clinical trial is planned ...